>
They're Using This War To 'Replace The Dollar'
What Schools Don't Teach You About American Indians
Wait what?! Farmers in Missouri & elsewhere have been finding boxes of Ticks?
"The greatest crime against humanity in recorded history… 81% of the women in one section...
China Introduces Pistol-Like Coil-Gun Based On Electromagnetic-Launch Systems
NEXT STOP: MARS IN JUST 30 DAYS?!
Poland's researchers discovered a bacteria strain that destroys pancreatic cancer.
Intel Partners with Tesla and SpaceX on Terafab
Anthropic Number One AI in Ranking and Revenue - Making $30 Billion Per Year
India's indigenous fast breeder reactor achieves critical stage: PM Modi
Mexico Speeds Up Biometric ID Rollout
Homemade solar drone smashes endurance record with 5+ hours aloft
This Home Flywheel Makes Storing Solar 90% Cheaper -- And It Works Forever!
Physicists captured a crystal made only of electrons, forming a honeycomb pattern without atoms...

The artificial heart was developed by a French company, CARMAT and has been approved for use and sale in Europe.
Last year, the company received U.S. FDA approval to begin studies and enroll 10 patients with end-stage biventricular heart failure—people who are suffering on the waiting list for a heart donor—and offer a life-saving bridge before transplant.
"We are encouraged that our patient is doing so well after the procedure Monday," said Dr. Carmelo Milano, a transplant surgeon and the principal investigator of the device study at Duke. "As we evaluate this device, we are both excited and hopeful that patients who otherwise have few to no options could have a lifeline."
The North Carolina patient, Matthew Moore, is just 39-years-old and was referred to Duke in June after a sudden, unexpected diagnosis of heart failure. Moore and his wife, Rachel, recently adopted their two-year-old foster son, Marshall, and arrived at Duke expecting only to undergo heart bypass surgery.